VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC (Q42723314)
Jump to navigation
Jump to search
scientific article published on November 29, 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC |
scientific article published on November 29, 2011 |
Statements
1 reference
VTX-2337 Is a Novel TLR8 Agonist That Activates NK Cells and Augments ADCC (English)
1 reference
Hailing Lu
1 reference
Yi Yang
1 reference
Smita Ghanekar
1 reference
Margaret Inokuma
1 reference
Maria Suni
1 reference
James Jeffry Howbert
1 reference
Gregory N. Dietsch
Maura-Ann H. Matthews
Vernon C. Maino
Katherine E. Henderson
Mary L. Disis
Robert M. Hershberg
29 November 2011
1 reference
1 reference
18
1 reference
2
1 reference
499-509
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference